Allspring Global Investments Holdings LLC boosted its holdings in Maximus, Inc. (NYSE:MMS – Free Report) by 0.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 705,302 shares of the health services provider’s stock after buying an additional 3,680 shares during the quarter. Allspring Global Investments Holdings LLC owned approximately 1.16% of Maximus worth $59,175,000 at the end of the most recent quarter.
Several other large investors have also recently bought and sold shares of the business. Verdence Capital Advisors LLC increased its holdings in Maximus by 3.2% in the fourth quarter. Verdence Capital Advisors LLC now owns 4,563 shares of the health services provider’s stock valued at $383,000 after buying an additional 140 shares during the last quarter. VisionPoint Advisory Group LLC grew its holdings in shares of Maximus by 61.4% during the third quarter. VisionPoint Advisory Group LLC now owns 381 shares of the health services provider’s stock worth $28,000 after purchasing an additional 145 shares during the last quarter. Bridge City Capital LLC grew its holdings in shares of Maximus by 0.8% during the first quarter. Bridge City Capital LLC now owns 24,182 shares of the health services provider’s stock worth $2,029,000 after purchasing an additional 188 shares during the last quarter. Retirement Systems of Alabama grew its holdings in shares of Maximus by 0.3% during the fourth quarter. Retirement Systems of Alabama now owns 76,128 shares of the health services provider’s stock worth $6,384,000 after purchasing an additional 232 shares during the last quarter. Finally, Virtu Financial LLC grew its holdings in shares of Maximus by 8.3% during the fourth quarter. Virtu Financial LLC now owns 3,102 shares of the health services provider’s stock worth $260,000 after purchasing an additional 237 shares during the last quarter. Hedge funds and other institutional investors own 97.21% of the company’s stock.
Maximus Stock Performance
Shares of MMS stock opened at $85.50 on Wednesday. The stock’s 50-day moving average is $85.29 and its two-hundred day moving average is $83.27. The firm has a market cap of $5.20 billion, a price-to-earnings ratio of 22.44 and a beta of 0.75. Maximus, Inc. has a 1 year low of $72.39 and a 1 year high of $90.65. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.53 and a current ratio of 1.53.
Maximus Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, May 31st. Stockholders of record on Wednesday, May 15th were paid a dividend of $0.30 per share. The ex-dividend date was Tuesday, May 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.40%. Maximus’s dividend payout ratio (DPR) is 31.50%.
Maximus Company Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Stories
- Five stocks we like better than Maximus
- 5 Top Rated Dividend Stocks to Consider
- RXO Shares Surge Following New Acquisition Deal
- Top Biotech Stocks: Exploring Innovation Opportunities
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.